These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3194931)

  • 21. Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage.
    Lozano M; Estebanell E; Cid J; Diaz-Ricart M; Mazzara R; Ordinas A; Escolar G
    Transfusion; 1999 Sep; 39(9):951-9. PubMed ID: 10533821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
    Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
    Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
    Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma-depleted platelet concentrates prepared with a new washing solution.
    Shimizu T; Shibata K; Kora S
    Vox Sang; 1993; 64(1):19-23. PubMed ID: 8447117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet activity in washed platelet concentrates.
    Schoenfeld H; Muhm M; Doepfmer U; Exadaktylos A; Radtke H
    Anesth Analg; 2004 Jul; 99(1):17-20. PubMed ID: 15281494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WBC content of platelet concentrates prepared by the buffy coat method using different processing procedures and storage solutions.
    de Wildt-Eggen J; Schrijver JG; Bins M
    Transfusion; 2001 Nov; 41(11):1378-83. PubMed ID: 11724981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of storage on the expression of platelet membrane phosphatidylserine and the subsequent impacton the coagulant function of stored platelets.
    Shapira S; Friedman Z; Shapiro H; Presseizen K; Radnay J; Ellis MH
    Transfusion; 2000 Oct; 40(10):1257-63. PubMed ID: 11061865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The functional integrity of platelets in volume-reduced platelet concentrates.
    Schoenfeld H; Muhm M; Doepfmer UR; Kox WJ; Spies C; Radtke H
    Anesth Analg; 2005 Jan; 100(1):78-81. PubMed ID: 15616055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet function in platelet concentrates and in whole blood.
    Rodgers SE; Lloyd JV; Russell WJ
    Anaesth Intensive Care; 1985 Nov; 13(4):355-61. PubMed ID: 2934002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates.
    Singh S; Shams Hakimi C; Jeppsson A; Hesse C
    Transfus Apher Sci; 2017 Dec; 56(6):870-874. PubMed ID: 29126740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Storage pool defect in pooled buffy coat platelet concentrates within the shelf-life period.
    Botchway AN; Flores NA; Sheridan DJ; Cohen H
    Clin Lab Haematol; 2000 Feb; 22(1):21-8. PubMed ID: 10762300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of prostaglandin E1 during preparation of platelet concentrates.
    Hawker RJ; Turner VS; Mitchell SG
    Transfus Med; 1996 Sep; 6(3):249-54. PubMed ID: 8885155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a cytokine-release assay to demonstrate loss of platelet secretory capacity during blood bank processing and storage.
    Tormey CA; Stack G
    Arch Pathol Lab Med; 2014 Nov; 138(11):1481-7. PubMed ID: 25357109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets.
    Krailadsiri P; Seghatchian J
    Vox Sang; 2000; 78(3):171-5. PubMed ID: 10838518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet function in reconstituted whole blood variants: An observational study over 5 days of storage time.
    Ponschab M; Schlimp CJ; Zipperle J; Gabriel C; Süssner S; Cadamuro J; Gratz J; Redl H; Schöchl H
    J Trauma Acute Care Surg; 2015 Nov; 79(5):797-804. PubMed ID: 26496104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buffy coat or platelet-rich plasma? Comparison of two platelet-processing techniques.
    Rácz Z; Thék M
    Vox Sang; 1984; 47(2):108-13. PubMed ID: 6464413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of procoagulant collagen- and thrombin-activated platelets in platelet concentrates derived from buffy coat: the role of processing, pathogen inactivation, and storage.
    Bertaggia Calderara D; Crettaz D; Aliotta A; Barelli S; Tissot JD; Prudent M; Alberio L
    Transfusion; 2018 Oct; 58(10):2395-2406. PubMed ID: 30229925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method.
    Muylle L; Wouters E; Peetermans ME
    Transfusion; 1996 Oct; 36(10):886-90. PubMed ID: 8863775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Technical problems in platelet-concentrate preparation and their clinical significance].
    Stampe D
    Infusionsther Klin Ernahr; 1977 Jun; 4(3):152-6. PubMed ID: 561028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.